This research report will give you deep insights about the defibrillator market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 115 pages. All our reports are usually purchased across industries by Executives, Managers, Senior Managers, Strategy people, Directors, Vice Presidents, CXOs, etc. and help them in understanding about the market trends and analysis, competition, industry landscape, market size, market revenue, forecast, COVID-19 impact analysis, SWOT analysis, etc.

The global defibrillator market is likely to expand considerably in the coming years due to the increasing incidence of out of hospital cardiac arrests. According to a report published by Fortune Business Insights, titled “Defibrillator: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 9,836.8 Mn in 2018. Fortune Business Insights states that the market will be valued at US$ 14,806.4 Mn by 2026, thereby exhibiting a CAGR of 5.3% during the forecast period.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/defibrillator-market-100950

Some of the key players in the global Defibrillator Market:

• Asahi Kasei Corporation
• Philips Healthcare
• Defibtech, LLC.
• Cardiac Science
• Stryker
• CU Medical System Inc.
• Medtronic Boston Scientific Corporation
• Biotronik
• LivaNova Plc,
• Abbott.

Boston Scientific Proposes a Defibrillator with 70% More Pacing Options

Boston Scientific receives FDA approval for its newest range of defibrillators, designed to better patient care. The company received approvals for Dynagen Mini and Inogen Mini, along with Dynagen X4 and Inogen X4. The company claims that the X4 lines of defibrillators offer 70% more pacing options for gathering elevated threshold levels.

The size of these devices are what differentiates them from its counterparts and it has created a rising uptake within end users. The company has submitted on its website that these devices are approximately 20% smaller than the existing devices, produced by its counterparts. The approvals for Boston Scientific’s latest devices is likely to enable the growth of the global market in the forthcoming years.

Some of the leading companies that are operating in the global defibrillator market are Asahi Kasei Corporation, Philips Healthcare, Defibtech, LLC., Cardiac Science, Stryker, CU Medical System Inc., Medtronic Boston Scientific Corporation, Biotronik, LivaNova Plc and Abbott.

About Us: Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us: Fortune Business Insights Pvt. Ltd. 9th Floor, Icon Tower, Baner - Mahalunge Road, Baner, Pune-411045, Maharashtra, India. Phone: US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245 Email: mailto:[email protected]